369 related articles for article (PubMed ID: 19896584)
21. Lower cerebral blood flow is associated with faster cognitive decline in Alzheimer's disease.
Benedictus MR; Leeuwis AE; Binnewijzend MA; Kuijer JP; Scheltens P; Barkhof F; van der Flier WM; Prins ND
Eur Radiol; 2017 Mar; 27(3):1169-1175. PubMed ID: 27334014
[TBL] [Abstract][Full Text] [Related]
22. Quantitative assessment of cerebral hemodynamic parameters by QUASAR arterial spin labeling in Alzheimer's disease and cognitively normal Elderly adults at 3-tesla.
Mak HK; Chan Q; Zhang Z; Petersen ET; Qiu D; Zhang L; Yau KK; Chu LW; Golay X
J Alzheimers Dis; 2012; 31(1):33-44. PubMed ID: 22504315
[TBL] [Abstract][Full Text] [Related]
23. Cerebral blood flow measured with 3D pseudocontinuous arterial spin-labeling MR imaging in Alzheimer disease and mild cognitive impairment: a marker for disease severity.
Binnewijzend MA; Kuijer JP; Benedictus MR; van der Flier WM; Wink AM; Wattjes MP; van Berckel BN; Scheltens P; Barkhof F
Radiology; 2013 Apr; 267(1):221-30. PubMed ID: 23238159
[TBL] [Abstract][Full Text] [Related]
24. MRI predictors of cognition in subcortical ischemic vascular disease and Alzheimer's disease.
Mungas D; Jagust WJ; Reed BR; Kramer JH; Weiner MW; Schuff N; Norman D; Mack WJ; Willis L; Chui HC
Neurology; 2001 Dec; 57(12):2229-35. PubMed ID: 11756602
[TBL] [Abstract][Full Text] [Related]
25. Pseudo-continuous arterial spin labeling quantifies cerebral blood flow in patients with acute ischemic stroke and chronic lacunar stroke.
Guo L; Zhang Q; Ding L; Liu K; Ding K; Jiang C; Liu C; Li K; Cui L
Clin Neurol Neurosurg; 2014 Oct; 125():229-36. PubMed ID: 25203634
[TBL] [Abstract][Full Text] [Related]
26. Different post label delay cerebral blood flow measurements in patients with Alzheimer's disease using 3D arterial spin labeling.
Liu Y; Zeng X; Wang Z; Zhang N; Fan D; Yuan H
Magn Reson Imaging; 2015 Nov; 33(9):1019-1025. PubMed ID: 26113261
[TBL] [Abstract][Full Text] [Related]
27. Different patterns of N-acetylaspartate loss in subcortical ischemic vascular dementia and AD.
Schuff N; Capizzano AA; Du AT; Amend DL; O'Neill J; Norman D; Jagust WJ; Chui HC; Kramer JH; Reed BR; Miller BL; Yaffe K; Weiner MW
Neurology; 2003 Aug; 61(3):358-64. PubMed ID: 12913198
[TBL] [Abstract][Full Text] [Related]
28. Longitudinal Cerebral Blood Flow Changes in Normal Aging and the Alzheimer's Disease Continuum Identified by Arterial Spin Labeling MRI.
Camargo A; Wang Z;
J Alzheimers Dis; 2021; 81(4):1727-1735. PubMed ID: 33967053
[TBL] [Abstract][Full Text] [Related]
29. Regional distribution of white matter hyperintensities in vascular dementia, Alzheimer's disease and healthy aging.
Gootjes L; Teipel SJ; Zebuhr Y; Schwarz R; Leinsinger G; Scheltens P; Möller HJ; Hampel H
Dement Geriatr Cogn Disord; 2004; 18(2):180-8. PubMed ID: 15211074
[TBL] [Abstract][Full Text] [Related]
30. Analysis of cerebral blood flow of subcortical vascular dementia with single photon emission computed tomography: adaptation of statistical parametric mapping.
Yang DW; Kim BS; Park JK; Kim SY; Kim EN; Sohn HS
J Neurol Sci; 2002 Nov; 203-204():199-205. PubMed ID: 12417384
[TBL] [Abstract][Full Text] [Related]
31. White matter lesions are associated with cortical atrophy more than entorhinal and hippocampal atrophy.
Du AT; Schuff N; Chao LL; Kornak J; Ezekiel F; Jagust WJ; Kramer JH; Reed BR; Miller BL; Norman D; Chui HC; Weiner MW
Neurobiol Aging; 2005 Apr; 26(4):553-9. PubMed ID: 15653183
[TBL] [Abstract][Full Text] [Related]
32. Subcortical ischaemic vascular dementia.
Román GC; Erkinjuntti T; Wallin A; Pantoni L; Chui HC
Lancet Neurol; 2002 Nov; 1(7):426-36. PubMed ID: 12849365
[TBL] [Abstract][Full Text] [Related]
33. High b-value diffusion imaging of dementia: application to vascular dementia and alzheimer disease.
Mayzel-Oreg O; Assaf Y; Gigi A; Ben-Bashat D; Verchovsky R; Mordohovitch M; Graif M; Hendler T; Korczyn A; Cohen Y
J Neurol Sci; 2007 Jun; 257(1-2):105-13. PubMed ID: 17360001
[TBL] [Abstract][Full Text] [Related]
34. White matter lesions impair frontal lobe function regardless of their location.
Tullberg M; Fletcher E; DeCarli C; Mungas D; Reed BR; Harvey DJ; Weiner MW; Chui HC; Jagust WJ
Neurology; 2004 Jul; 63(2):246-53. PubMed ID: 15277616
[TBL] [Abstract][Full Text] [Related]
35. Quantitative analysis of brain perfusion SPECT in Alzheimer's disease using a fully automated regional cerebral blood flow quantification software, 3DSRT.
Kobayashi S; Tateno M; Utsumi K; Takahashi A; Saitoh M; Morii H; Fujii K; Teraoka M
J Neurol Sci; 2008 Jan; 264(1-2):27-33. PubMed ID: 17764699
[TBL] [Abstract][Full Text] [Related]
36. Multivariate and univariate analysis of continuous arterial spin labeling perfusion MRI in Alzheimer's disease.
Asllani I; Habeck C; Scarmeas N; Borogovac A; Brown TR; Stern Y
J Cereb Blood Flow Metab; 2008 Apr; 28(4):725-36. PubMed ID: 17960142
[TBL] [Abstract][Full Text] [Related]
37. Abnormal intrinsic brain activity patterns in patients with subcortical ischemic vascular dementia.
Liu C; Li C; Yin X; Yang J; Zhou D; Gui L; Wang J
PLoS One; 2014; 9(2):e87880. PubMed ID: 24498389
[TBL] [Abstract][Full Text] [Related]
38. Neurovascular Correlates of Cobalamin, Folate, and Homocysteine in Dementia.
Tu MC; Chung HW; Hsu YH; Yang JJ; Wu WC
J Alzheimers Dis; 2023; 96(3):1329-1338. PubMed ID: 37980672
[TBL] [Abstract][Full Text] [Related]
39. Magnetic resonance imaging-measured atrophy and its relationship to cognitive functioning in vascular dementia and Alzheimer's disease patients.
Logue MW; Posner H; Green RC; Moline M; Cupples LA; Lunetta KL; Zou H; Hurt SW; Farrer LA; Decarli C;
Alzheimers Dement; 2011 Sep; 7(5):493-500. PubMed ID: 21723205
[TBL] [Abstract][Full Text] [Related]
40. Sorting out the clinical consequences of ischemic lesions in brain aging: a clinicopathological approach.
Gold G; Kovari E; Hof PR; Bouras C; Giannakopoulos P
J Neurol Sci; 2007 Jun; 257(1-2):17-22. PubMed ID: 17321551
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
